FDA Inspection
Ferring Pharmaceuticals IncFerring Pharmaceuticals Inc – FDA Inspection, Mar 14, 2023
Record Details
This FDA Inspection record concerns Ferring Pharmaceuticals Inc, with an inspection on March 14, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 63a5dce9-cb0a-467f-bec3-74df8fd3ec5a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1199698
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 312.50General responsibilities of sponsors
- 21 CFR 312.50General responsibilities of sponsors
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Ferring Pharmaceuticals Inc
5| Date | Classification | Office | Project area |
|---|---|---|---|
| June 9, 2025 | Not classified | New Jersey District Office | |
| August 24, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| July 14, 2016 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| September 20, 2011 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 3, 2008 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Ferring Pharmaceuticals Inc
- FDA Inspection 1272776 - 2025-06-09
- FDA Inspection 1129293 - 2020-08-24
- FDA Inspection 980257 - 2016-07-14
- FDA Inspection 749710 - 2011-09-20
- FDA Inspection 542082 - 2008-10-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.